Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Maria Carmen Frigola Deulofeu has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13710851

USE OF A PYRAZOLE DERIVATIVE IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 31/415, A61P 11/00
Applicant:
Novartis AG
Agent:
Lionel Paul Clarke, Gill Jennings & Every LLP
Agent:
Maria Carmen Frigola Deulofeu, Novartis Pharma AG
Status:
PATENT GRANTED
EP12705203

DRY POWDER FORMULATIONS OF PARTICLES THAT CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATING OBSTRUCTIVE OR INFLAMMATORY AIRWAYS DISEASES

IPC classification:
A61K 31/4704, A61K 31/58, A61K 31/56, A61K 31/40, A61K 9/50, A61K 9/16, A61M 15/00, A61K 45/06, A61P 11/00, A61K 9/00, A61K 9/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED

Please Sign in to use this feature